share_log

BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $43

BMO Capital Maintains Market Perform on Ingevity, Lowers Price Target to $43

BMO Capital維持Ingevity的市場表現,將目標股價下調至43美元
Benzinga ·  2023/11/09 14:32

BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Market Perform and lowers the price target from $54 to $43.

BMO Capital分析師約翰·麥克納爾蒂維持Ingevity(紐約證券交易所代碼:NGVT)的市場表現,並將目標股價從54美元下調至43美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論